Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Macugen	403
Overall Study	STARTED	Macugen and Avastin	16
Overall Study	STARTED	Macugen and Lucentis	75
Overall Study	STARTED	Macugen and Other AMD Drugs	7
Overall Study	COMPLETED	Macugen	336
Overall Study	COMPLETED	Macugen and Avastin	13
Overall Study	COMPLETED	Macugen and Lucentis	69
Overall Study	COMPLETED	Macugen and Other AMD Drugs	7
Overall Study	NOT COMPLETED	Macugen	67
Overall Study	NOT COMPLETED	Macugen and Avastin	3
Overall Study	NOT COMPLETED	Macugen and Lucentis	6
Overall Study	NOT COMPLETED	Macugen and Other AMD Drugs	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00460408/flow